431 related articles for article (PubMed ID: 20350562)
1. Enhanced expression of Nrf2 in mice attenuates the fatty liver produced by a methionine- and choline-deficient diet.
Zhang YK; Yeager RL; Tanaka Y; Klaassen CD
Toxicol Appl Pharmacol; 2010 Jun; 245(3):326-34. PubMed ID: 20350562
[TBL] [Abstract][Full Text] [Related]
2. Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice.
Sugimoto H; Okada K; Shoda J; Warabi E; Ishige K; Ueda T; Taguchi K; Yanagawa T; Nakahara A; Hyodo I; Ishii T; Yamamoto M
Am J Physiol Gastrointest Liver Physiol; 2010 Feb; 298(2):G283-94. PubMed ID: 19926817
[TBL] [Abstract][Full Text] [Related]
3. Nrf2 inhibits hepatic iron accumulation and counteracts oxidative stress-induced liver injury in nutritional steatohepatitis.
Okada K; Warabi E; Sugimoto H; Horie M; Tokushige K; Ueda T; Harada N; Taguchi K; Hashimoto E; Itoh K; Ishii T; Utsunomiya H; Yamamoto M; Shoda J
J Gastroenterol; 2012 Aug; 47(8):924-35. PubMed ID: 22367278
[TBL] [Abstract][Full Text] [Related]
4. Nrf2 deficiency improves glucose tolerance in mice fed a high-fat diet.
Zhang YK; Wu KC; Liu J; Klaassen CD
Toxicol Appl Pharmacol; 2012 Nov; 264(3):305-14. PubMed ID: 23017736
[TBL] [Abstract][Full Text] [Related]
5. Keap1-knockdown decreases fasting-induced fatty liver via altered lipid metabolism and decreased fatty acid mobilization from adipose tissue.
Xu J; Donepudi AC; Moscovitz JE; Slitt AL
PLoS One; 2013; 8(11):e79841. PubMed ID: 24224011
[TBL] [Abstract][Full Text] [Related]
6. Increased Nrf2 activation in livers from Keap1-knockdown mice increases expression of cytoprotective genes that detoxify electrophiles more than those that detoxify reactive oxygen species.
Reisman SA; Yeager RL; Yamamoto M; Klaassen CD
Toxicol Sci; 2009 Mar; 108(1):35-47. PubMed ID: 19129213
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets.
Fisher FM; Chui PC; Nasser IA; Popov Y; Cunniff JC; Lundasen T; Kharitonenkov A; Schuppan D; Flier JS; Maratos-Flier E
Gastroenterology; 2014 Nov; 147(5):1073-83.e6. PubMed ID: 25083607
[TBL] [Abstract][Full Text] [Related]
8. Attenuated progression of diet-induced steatohepatitis in glutathione-deficient mice.
Haque JA; McMahan RS; Campbell JS; Shimizu-Albergine M; Wilson AM; Botta D; Bammler TK; Beyer RP; Montine TJ; Yeh MM; Kavanagh TJ; Fausto N
Lab Invest; 2010 Dec; 90(12):1704-17. PubMed ID: 20548286
[TBL] [Abstract][Full Text] [Related]
9. Hepatic effects of a methionine-choline-deficient diet in hepatocyte RXRalpha-null mice.
Gyamfi MA; Tanaka Y; He L; Klaassen CD; Wan YJ
Toxicol Appl Pharmacol; 2009 Jan; 234(2):166-78. PubMed ID: 18952117
[TBL] [Abstract][Full Text] [Related]
10. Altered disposition of acetaminophen in Nrf2-null and Keap1-knockdown mice.
Reisman SA; Csanaky IL; Aleksunes LM; Klaassen CD
Toxicol Sci; 2009 May; 109(1):31-40. PubMed ID: 19246624
[TBL] [Abstract][Full Text] [Related]
11. Alcohol dehydrogenase 3 contributes to the protection of liver from nonalcoholic steatohepatitis.
Goto M; Kitamura H; Alam MM; Ota N; Haseba T; Akimoto T; Shimizu A; Takano-Yamamoto T; Yamamoto M; Motohashi H
Genes Cells; 2015 Jun; 20(6):464-80. PubMed ID: 25777368
[TBL] [Abstract][Full Text] [Related]
12. Role of Nrf2 in preventing ethanol-induced oxidative stress and lipid accumulation.
Wu KC; Liu J; Klaassen CD
Toxicol Appl Pharmacol; 2012 Aug; 262(3):321-9. PubMed ID: 22627062
[TBL] [Abstract][Full Text] [Related]
13. Sitagliptin attenuates methionine/choline-deficient diet-induced steatohepatitis.
Jung YA; Choi YK; Jung GS; Seo HY; Kim HS; Jang BK; Kim JG; Lee IK; Kim MK; Park KG
Diabetes Res Clin Pract; 2014 Jul; 105(1):47-57. PubMed ID: 24842243
[TBL] [Abstract][Full Text] [Related]
14. The pathogenesis of ethanol versus methionine and choline deficient diet-induced liver injury.
Gyamfi MA; Damjanov I; French S; Wan YJ
Biochem Pharmacol; 2008 Feb; 75(4):981-95. PubMed ID: 18036573
[TBL] [Abstract][Full Text] [Related]
15. Nrf2 protects against furosemide-induced hepatotoxicity.
Qu Q; Liu J; Zhou HH; Klaassen CD
Toxicology; 2014 Oct; 324():35-42. PubMed ID: 24813929
[TBL] [Abstract][Full Text] [Related]
16. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis.
Lee DH; Han DH; Nam KT; Park JS; Kim SH; Lee M; Kim G; Min BS; Cha BS; Lee YS; Sung SH; Jeong H; Ji HW; Lee MJ; Lee JS; Lee HY; Chun Y; Kim J; Komatsu M; Lee YH; Bae SH
Free Radic Biol Med; 2016 Oct; 99():520-532. PubMed ID: 27634173
[TBL] [Abstract][Full Text] [Related]
17. Nrf2 activation enhances biliary excretion of sulfobromophthalein by inducing glutathione-S-transferase activity.
Reisman SA; Csanaky IL; Yeager RL; Klaassen CD
Toxicol Sci; 2009 May; 109(1):24-30. PubMed ID: 19246623
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Nrf2 activity worsens insulin resistance, impairs lipid accumulation in adipose tissue, and increases hepatic steatosis in leptin-deficient mice.
Xu J; Kulkarni SR; Donepudi AC; More VR; Slitt AL
Diabetes; 2012 Dec; 61(12):3208-18. PubMed ID: 22936178
[TBL] [Abstract][Full Text] [Related]
19. Stress signaling in the methionine-choline-deficient model of murine fatty liver disease.
Soon RK; Yan JS; Grenert JP; Maher JJ
Gastroenterology; 2010 Nov; 139(5):1730-9, 1739.e1. PubMed ID: 20682321
[TBL] [Abstract][Full Text] [Related]
20. CCAAT/enhancing binding protein beta deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis.
Rahman SM; Schroeder-Gloeckler JM; Janssen RC; Jiang H; Qadri I; Maclean KN; Friedman JE
Hepatology; 2007 May; 45(5):1108-17. PubMed ID: 17464987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]